Orai1チャネル阻害は,左心室シストリック機能と圧力過負荷後の正常なCa2+処理を維持する
Fiona Bartoli1, Marc A Bailey2, Baptiste Rode2
1Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin).
Circulation
|January 8, 2020
まとめ
心臓のOrai1チャネルは高縮と心不全の鍵です Orai1を阻害すると,心臓機能不全から保護され,高縮性ストレス後の収縮性が維持され,Orai1阻害剤が潜在的な治療法であると示唆される.
科学分野:
- 心血管研究
- イオンチャンネル生理学
- 分子心臓科
背景:
- Orai1は,非刺激性細胞において重要な,貯蔵されたCa2+エントリー (SOCE) を媒介する.
- SOCEは心臓の膨張や心不全に 関連している.
- 心臓病理学におけるOrai1の特定の役割は不明である.
研究 の 目的:
- 心臓の縮と機能障害における Orai1 経路の役割を調査する.
- 心臓縮のマウスモデルにおけるOrai1抑制の治療の可能性を評価する.
主な方法:
- 心筋細胞特有のOrai1ノックダウンマウスモデル (C-dnO1) を生成した.
- 小分子 Orai1 阻害剤 (JPIII) を in vivo 研究に使用した.
- マウスにおける横動脈収縮 (TAC) による誘発性心筋縮.
主要な成果:
- TACは心筋縮,機能不全,およびOrai1依存性SOCEを増加させた.
- C-dnO1マウスは,TAC誘発のシストリック機能障害と心臓のCa2+シグナル変化から保護された.
- また,JPIIIによるOrai1阻害は,高縮性傷害に対する保護効果を示した.
結論:
- 心臓のOrai1チャネルは,心筋縮と機能不全の発生に重要な役割を果たします.
- Orai1抑制は,高圧性ストレス下での心臓収縮性の維持のための有望な治療戦略です.
関連する概念動画
Antihypertensive Drugs: Action of Calcium Channel Blockers
1.4K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.2K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy
396
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
396
Feedback Regulation of Calcium Concentration
3.8K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.8K
Heart Failure II: Pathophysiology
612
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
612


